Financial Performance - For the nine months ended September 30, 2024, the company's unaudited consolidated revenue was HKD 8,584.97 million, an increase of 10.3% compared to HKD 7,786.51 million for the same period last year[3]. - The company's unaudited consolidated operating profit for the same period was HKD 189.77 million, a decrease of 11.2% from HKD 213.76 million year-on-year[3]. - The unaudited consolidated profit attributable to shareholders was HKD 115.82 million, representing an 18.0% increase from HKD 98.12 million as of December 31, 2023[3]. Business Segments - The food biological business generated revenue of HKD 7,068.00 million, a 16.4% increase year-on-year, with a segment profit of HKD 156.70 million, up 2.3%[6]. - The live pig slaughter volume exceeded 2.29 million heads, with a market share in Guangdong province ranking among the top[6]. - The tinplate business recorded a revenue of HKD 1,504.00 million, a decrease of 11.6%, with a segment profit of HKD 32.83 million, down 53.7%[7]. Asset and Equity - Total assets as of September 30, 2024, were HKD 4,832.80 million, a 0.9% increase from HKD 4,789.00 million[3]. - Shareholders' equity increased by 2.2% to HKD 2,627.54 million from HKD 2,570.01 million[3]. Market Conditions - The company expects continued volatility in pig prices and fluctuations in customer demand and raw material prices affecting the food biological and tinplate businesses[9]. - The value of the investment properties held by the group decreased, resulting in a valuation loss of HKD 6.75 million for the period[8].
广南(集团)(01203) - 2024 Q3 - 季度业绩